Literature DB >> 12677304

Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer.

S Mirzaei1, M Rodrigues, B Hoffmann, P Knoll, M Riegler-Keil, W Kreuzer, H Salzer, H Köhn, A Polyák, G A Jánoki.   

Abstract

Detection of metastatic involvement of lymph nodes is essential for management and prognostic evaluation in breast cancer patients. The success of lymphatic mapping depends on identifying the sentinel lymph node(s) draining the primary tumour. However, when mapping is performed with a radiocolloidal agent, the number of hot lymph nodes varies with the agent and its size, among other factors. In this study, we evaluated prospectively the detection rate of sentinel lymph nodes in breast cancer when injecting large particles (100-600 nm) of human serum albumin colloids (Senti-Scint). In 128 consecutive breast cancer patients without palpable lymph nodes, pre-operative static lymphoscintigraphic mapping of the breast was performed after subcutaneous injection of 15 MBq of the radiocolloid. Lymphoscintigrahic results were compared with intra-operative surgical gamma detection probe and blue dye mapping data. Pre-operative lymphoscintigraphy and surgical gamma detection probe both correctly detected 203 sentinel lymph nodes in 122/128 patients (95%), while blue dye mapping showed only 183 sentinel lymph nodes in 82% of the patients. Only one or two sentinel lymph nodes were identified in each patient, which allowed the surgeon easily to find the sentinel lymph node(s) intra-operatively. In conclusion, lymphoscintigraphy with large particles of human serum albumin colloids is a helpful and reliable procedure for the surgical management of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12677304     DOI: 10.1007/s00259-003-1147-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  14 in total

Review 1.  Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations.

Authors:  D Eshima; T Fauconnier; L Eshima; J R Thornback
Journal:  Semin Nucl Med       Date:  2000-01       Impact factor: 4.446

Review 2.  Radiopharmaceuticals in sentinel lymph-node detection - an overview.

Authors:  A J Wilhelm; G S Mijnhout; E J Franssen
Journal:  Eur J Nucl Med       Date:  1999-04

3.  Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

Authors:  C De Cicco; M Cremonesi; A Luini; M Bartolomei; C Grana; G Prisco; V Galimberti; P Calza; G Viale; U Veronesi; G Paganelli
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

Review 4.  Sentinel lymph node detection and imaging.

Authors:  M R Keshtgar; P J Ell
Journal:  Eur J Nucl Med       Date:  1999-01

5.  The hidden sentinel node in breast cancer.

Authors:  P J Tanis; J W van Sandick; O E Nieweg; R A Valdés Olmos; E J T Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

6.  An approach for the treatment of penile carcinoma.

Authors:  R M Cabanas
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

7.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

8.  Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.

Authors:  L Tafra; D R Lannin; M S Swanson; K M Verbanac; A N Chua; P C Ng; M S Edwards; B E Halliday; C A Henry; L M Sommers; C M Carman; M R Molin; J E Yurko; R R Perry; R Williams
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

9.  Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.

Authors:  U Veronesi; F Rilke; A Luini; V Sacchini; V Galimberti; T Campa; E Dei Bei; M Greco; A Magni; M Merson
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

10.  Patterns of axillary lymph node metastasis in breast cancer.

Authors:  M Van Lancker; C Goor; R Sacre; J Lamote; S Van Belle; N De Coene; A Roelstraete; G Storme
Journal:  Am J Clin Oncol       Date:  1995-06       Impact factor: 2.339

View more
  3 in total

1.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study.

Authors:  Xuejuan Wang; Zhi Yang; Baohe Lin; Yan Zhang; Shizhen Zhai; Qichao Zhao; Qing Xie; Fei Liu; Xuedi Han; Jinfeng Li; Tao Ouyang
Journal:  Oncotarget       Date:  2016-06-21

3.  99mTc-labeled sodium phytate and stannous chloride injection accurately detects sentinel lymph node in axillary of early stage breast cancer: a randomized, controlled study.

Authors:  Suisheng Yang; Weiyu Bao; Xiaorong Bai; Chen Gao; Binming Zhang; Zhuanji Jiang
Journal:  Onco Targets Ther       Date:  2018-04-04       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.